INS and Hypoglycemia: Similarly, the incidence of serious hypoglycemic episodes and nocturnal hypoglycemia was lower during the 6-month study period than over the same time period preceding basal insulin analogue treatment (p < 0.001 vs. 6 months before insulin analogue treatment).